Sleep Apnea Devices Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031
Sleep Apnea Devices Market Overview:
The Sleep
Apnea Devices Market was valued at $5.5 billion in 2021 and is projected to
grow at a CAGR of 7% through 2031. Growth is being driven by a substantial
population of undiagnosed patients, increasing adoption of home-based sleep
testing, supportive reimbursement policies in major markets such as the United
States, rising awareness of the health risks associated with untreated sleep
apnea, expanding funding initiatives to improve OSA diagnosis and treatment,
and the entry of new companies into the space. However, limited patient
adherence—particularly to CPAP therapy—remains a significant barrier to
sustained market expansion.
Download Sample PDF Copy: https://meditechinsights.com/sleep-apnea-devices-market/request-sample/
Obstructive sleep apnea (OSA), the most prevalent type
of sleep-disordered breathing (SDB), occurs when the upper airway partially or
completely collapses due to relaxation of the soft palate and tongue muscles
during sleep. Globally, an estimated one billion adults aged 30 to 69 are
affected by OSA. The condition’s severity is assessed using the Apnea-Hypopnea
Index (AHI), which measures the number of apnea or hypopnea events per hour:
- Normal: AHI < 5 events/hour
- Mild: 5 ≤ AHI < 15 events/hour
- Moderate: 15 ≤ AHI < 30 events/hour
- Severe: AHI ≥ 30 events/hour
OSA prevalence is steadily increasing and is estimated
to affect approximately 3% to 20% of the general population.
Technological Advancements Driving
Market Growth
The sleep apnea devices market is highly
technology-driven, characterized by ongoing innovation and product
enhancements. For example, in October 2021, AirAvant Medical launched Bongo Rx,
a CPAP alternative designed to treat mild to moderate OSA. The device is
inserted into the nostrils during sleep to maintain airflow by creating a seal
as the user breathes.
In August 2021, ResMed introduced AirSense 11, its
next-generation positive airway pressure (PAP) device. The system features
tools such as the Personal Therapy Assistant and Care Check-In to provide
customized guidance and improve therapy adherence. It also supports remote
software updates, enabling patients to access the latest features without
replacing the device.
In April 2021, Somne announced development of a
non-invasive CPAP alternative worn around the neck. Using patented Variable
Negative Pressure (UNEP) technology, the device delivers therapy during sleep
without traditional airway masks.
Growing Shift Toward Home Sleep Apnea
Testing (HSAT)
Traditionally, sleep apnea diagnosis required an
overnight stay in a sleep laboratory, where multiple sensors were attached to
monitor heart rate, brain activity, muscle movement, breathing patterns, and
other physiological parameters. These studies were comprehensive but often
costly and inconvenient.
Today, home sleep apnea testing (HSAT) is gaining
popularity. HSAT is conducted outside of a hospital or sleep lab using a
portable monitoring device that tracks sleep-related breathing parameters
overnight. These tests are typically more affordable—ranging from approximately
$200 to $600—compared to $800 to $3,000 for in-lab studies. HSAT also requires
fewer sensors and allows patients to undergo testing in the comfort of their
homes. Increasingly, insurers are requiring HSAT as an initial diagnostic step
before approving coverage for in-lab testing.
Download Sample PDF Copy: https://meditechinsights.com/sleep-apnea-devices-market/request-sample/
Favorable Reimbursement Policies in
Key Markets
In the United States, Medicare Part B covers diagnostic
testing and treatment for OSA when established criteria are met. Covered
diagnostic services include oximetry testing, polysomnography, in-lab sleep
studies, and home sleep studies. Treatment options eligible for coverage
include continuous positive airway pressure (CPAP) devices, bilevel positive
airway pressure (BiPAP) systems, respiratory assist devices, and mandibular
advancement oral appliances. Such reimbursement support significantly enhances
patient access and contributes to market growth.
Strategic Initiatives Strengthening
Market Position
The competitive landscape includes both established
players and emerging companies pursuing organic and inorganic growth strategies
such as product launches, acquisitions, and partnerships.
For instance, in December 2021, ZOLL Medical
Corporation acquired Itamar Medical Ltd., a company specializing in at-home
sleep apnea diagnostics. In February 2021, GoPAPfree introduced the O2Vent
Optima oral appliance, featuring integrated airway technology designed to
improve therapy response rates and reduce snoring.
Browse Report: https://meditechinsights.com/sleep-apnea-devices-market/
Market Outlook and Competitive
Landscape
The sleep apnea devices market is poised for sustained
growth, supported by continuous technological innovation, increased awareness
campaigns by governments and manufacturers, rising adoption of oral appliances
due to their convenience and portability, and advancements such as compliance tracking
and remote adjustment technologies that optimize airway patency over time.
Key companies operating in the market include ResMed,
Philips Respironics, Fisher & Paykel Healthcare, SomnoMed,
Itamar Medical, Inspire Medical Systems, Compumedics, Oventus
Medical, Natus Medical, Drive DeVilbiss Healthcare, Whole
You, and BMC Medical, among others.
Related Report:
Large Molecule Drug Substance CDMO Market https://www.pharmiweb.com/press-release/2026-02-25/large-molecule-drug-substance-cdmo-market-2026-size-share-trends-and-growth-by-forecast-2030
Pharmerging Market https://www.pharmiweb.com/press-release/2026-02-25/pharmerging-market-analysis-size-share-top-companies-and-research-report-by-2029
Artificial Intelligence (AI) in Drug Discovery Market https://www.pharmiweb.com/press-release/2026-02-25/artificial-intelligence-ai-in-drug-discovery-market-size-growth-and-forecast-2025-2029
Radioligand Therapy (RLT) Market https://www.pharmiweb.com/press-release/2026-02-25/radioligand-therapy-rlt-market-research-report-analysis-size-share-trends-and-forecast-2030
Medical Tourism Market https://www.pharmiweb.com/press-release/2026-02-25/medical-tourism-market-research-report-analysis-size-share-trends-and-forecast-2029
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment